Literature DB >> 19179475

Trisomy 13: prevalence and clinicopathologic correlates of another potentially lenalidomide-sensitive cytogenetic abnormality.

Ruben A Mesa, Curtis A Hanson, Rhett P Ketterling, Susan Schwager, Ryan A Knudson, Ayalew Tefferi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19179475     DOI： 10.1182/blood-2008-10-182170

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Number of RUNX1 mutations, wild-type allele loss and additional mutations impact on prognosis in adult RUNX1-mutated AML.

Authors:  A Stengel; W Kern; M Meggendorfer; N Nadarajah; K Perglerovà; T Haferlach; C Haferlach
Journal:  Leukemia       Date:  2017-07-28       Impact factor: 11.528

Review 2.  Rare cytogenetic abnormalities in myelodysplastic syndromes.

Authors:  Ulrike Bacher; Julie Schanz; Friederike Braulke; Detlef Haase
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-05-01       Impact factor: 2.576

3.  The new provisional WHO entity 'RUNX1 mutated AML' shows specific genetics but no prognostic influence of dysplasia.

Authors:  T Haferlach; A Stengel; S Eckstein; K Perglerová; T Alpermann; W Kern; C Haferlach; M Meggendorfer
Journal:  Leukemia       Date:  2016-05-23       Impact factor: 11.528

Review 4.  Cytogenetic Abnormalities in Myelodysplastic Syndromes: An Overview.

Authors:  Mohammad Faizan Zahid; Umair Arshad Malik; Momena Sohail; Irfan Nazir Hassan; Sara Ali; Muhammad Hamza Saad Shaukat
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2017-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.